J&J boosts investments in U.S. to more than $55 billion amid looming tariff threats

Johnson & Johnson plans to spend over $55 billion to build four plants in the U.S., it said on Friday, as a threat of drug import duties from the Trump administration forces companies to expand their manufacturing operations domestically.